Bosanac
Alex Bosanac, Toronto CA
Patent application number | Description | Published |
---|---|---|
20080218383 | SYSTEM AND METHOD FOR PARKING INFRACTION DETECTION - The invention relates to a system and method for detecting parking infractions. It comprises computing one or more measurements associated with a stationary object found at a first location; classifying the stationary object as being representative of a vehicle parked at the first location based on the one or more measurements associated with the stationary object; capturing one or more images of the vehicle parked at the first location; processing the one or more images of the vehicle to extract one or more present vehicle identifiers associated with the vehicle, and recording a time the one or more images were taken, a co-ordinate set associated with the first location and the one or more identifiers associated with the vehicle; determining a time duration for which parking is allowed at the first location; and comparing the present vehicle identifiers with previously recorded vehicle identifiers associated with the first location to determine if the vehicle has been parked at the first location for a period exceeding the time duration. | 09-11-2008 |
Ivan Bosanac, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20110129457 | VARIANT HHIP1 PROTEIN AND METHODS AND USES THEREOF - The present invention is directed to derivatives of Hhip1 and methods of using the same for treatment and diagnosis of cancer in mammals. | 06-02-2011 |
Todd Bosanac, New Milford, CT US
Patent application number | Description | Published |
---|---|---|
20090325988 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof - Compounds of Formula (I) | 12-31-2009 |
20110275627 | INDOLIZINE INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compounds of formula (I): | 11-10-2011 |
20120214787 | OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compounds of formula (I): | 08-23-2012 |
20120220561 | OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compound of formula (I): | 08-30-2012 |
20120245162 | OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compounds of formula (I): | 09-27-2012 |
20120295896 | OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compounds of formula (I) and (IA): | 11-22-2012 |
20130203729 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS - The present invention relates to compounds of formula (I): | 08-08-2013 |
20140045813 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS - The present invention encompasses compounds of the formula (I) | 02-13-2014 |
20140275012 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS - The present invention encompasses compounds of the formula (I) | 09-18-2014 |
20140275014 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS - The present invention encompasses compounds of the formula (I) | 09-18-2014 |
20140357652 | RHO KINASE INHIBITORS - Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds. | 12-04-2014 |